Comparative in vitro microbiological activity and stability of cefaclor.

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Oral cephalosporins are widely used for bacterial infections.
• Emerging bacterial resistance necessitates the development of new antimicrobial agents.
• Comparative in vitro studies are crucial for evaluating antibiotic efficacy.

Purpose of the Study:

• To compare the in vitro antimicrobial activity of cefaclor against cephalexin and cephradine.
• To assess the efficacy of cefaclor against specific bacterial pathogens, including Haemophilus influenzae, Neisseria gonorrhoeae, and Enterobacteriaceae.
• To identify potential limitations or areas for further investigation regarding cefaclor's properties.

Main Methods:

• In vitro susceptibility testing was performed.
• Cefaclor, cephalexin, and cephradine were evaluated.
• Activity against specific bacterial strains, including Haemophilus influenzae (beta-lactamase producing and non-producing), Neisseria gonorrhoeae, and Enterobacteriaceae, was assessed.

Main Results:

• Cefaclor demonstrated the highest in vitro activity among the oral agents tested against Haemophilus influenzae, particularly non-beta-lactamase producing strains.
• Cefaclor exhibited significantly greater activity against Neisseria gonorrhoeae and Enterobacteriaceae compared to cephalexin and cephradine.
• Instability of cefaclor in agar was observed, indicating a need for further study.

Conclusions:

• Cefaclor represents a promising oral antibiotic with enhanced in vitro activity against several important bacterial pathogens.
• Its superior efficacy against Haemophilus influenzae and Neisseria gonorrhoeae warrants clinical consideration.
• The observed agar instability requires further investigation to fully understand its clinical implications.